MichaelJamieHochmanMD(He/Him)

Hematology • Atlanta, GA

Hematologic Oncology

Assistant Professor

Join to view full profile

Dr. Hochman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Hochman's full profile

Already have an account?

Office
1365 Clifton Road, NE
Building B, Suite B4000
Atlanta, GA 30322
Phone+1 404-778-5536

Fax+1 404-778-4755

Clinical Expertise

Acute myeloid leukemia, Myeloproliferative neoplasms, Myelodysplastic syndromes

Education & Training

Johns Hopkins UniversityFellowship, Hematology, 2020 - 2023
University of WashingtonResidency, Internal Medicine, 2017 - 2020
Duke University School of MedicineClass of 2017

Certifications & Licensure

GA State Medical License 2023 - 2026
MD State Medical License 2021 - 2024
WA State Medical License 2019 - 2020
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

ASH Abstract Achievement Award American Society of Hematology, 2022

Publications & Presentations

PubMed

2 citations
Prognostic impact of secondary versus de novo ontogeny in acute myeloid leukemia is accounted for by the European LeukemiaNet 2022 risk classification.
Michael J Hochman, Megan Othus, Robert P Hasserjian, Alex Ambinder, Andrew Brunner
Leukemia. 2023-09-01
13 citations
Myelodysplastic syndrome and autoimmune disorders: two sides of the same coin?
Michael J Hochman, Amy E DeZern
The Lancet. Haematology. 2022-07-01
63 citations
Comparing the Palliative Care Needs of Patients With Hematologic and Solid Malignancies.
Michael J. Hochman, Yinxi Yu, Steven Wolf, Greg Samsa, Arif H. Kamal
Journal of Pain and Symptom Management. 2018-01-01

Lectures

Does intensity of induction chemotherapy affect the impact of measurable residual disease (MRD) on prognosis in acute myeloid leukemia (AML)?
2019 ASCO Annual Meeting - 6/1/2019

Professional Memberships

American Society of Clinical Oncology - ASCO
Member
American Society of Hematology - ASH
Member
Society of Hematologic Oncology
Member

External Links

Emory Profilehttps://winshipcancer.emory.edu/bios/faculty/hochman-michael